1. An innovative anticonvulsant - a GABAA receptor modulator with an alternative mechanism of action and enzyme-inducing detoxifying properties. (13th April 2021) Authors: Shushpanova, T.; Bokhan, N.; Stankevich, K.; Novozheeva, T.; Shushpanova, O.; Udut, V.; Garganeeva, N.; Markova, E.; Knyazeva, E.; Safronov, S.; Boev, R.; Solonskii, A. Journal: European psychiatry Issue: Volume 64:Supplement 1(2021) Page Start: S777 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. The original anticonvulsant meta-Cl-benzhydrylurea (m-CL-BHM) induces of the liver monooxygenase system and stimulates the neuroimmune response in behavioral disorders of alcoholic origin. (1st June 2022) Authors: Shushpanova, Т.; Novozheeva, T.; Gutkevich, E.; Pustovaya, A.; Garganeeva, N.; Belousov, M.; Podyablonsky, A.; Markova, E.; Knyazeva, E.; Shushpanova, O.; Kolomiets, N.; Safronov, S.; Boev, R. Journal: European psychiatry Issue: Volume 65:Supplement 1(2022) Page Start: S819 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗